New Chemical Modalities and Strategic Thinking in Early Drug Discovery

被引:80
|
作者
Blanco, Maria-Jesus [1 ]
Gardinier, Kevin M. [2 ]
机构
[1] Sage Therapeut Inc, Med Chem, 215 First St, Cambridge, MA 02142 USA
[2] Novartis Inst BioMed Res, Global Discovery Chem, 22 Windsor St, Cambridge, MA 02139 USA
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2020年 / 11卷 / 03期
关键词
Chemical modalities; RNA; PROTAC; cyclopeptides; target validation; strategy; TARGET;
D O I
10.1021/acsmedchemlett.9b00582
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The classical toolbox for drug discovery is continuously expanding beyond traditional small molecules. New chemical modalities including RNA therapeutics, protein degraders, cyclopeptides, antibody drug conjugates, and gene therapy have matured, demonstrating clinical success and are now considered early in target appraisal. In this Viewpoint, we highlight recent progress in the field.
引用
收藏
页码:228 / 231
页数:4
相关论文
共 50 条
  • [1] New Modalities for Challenging Targets in Drug Discovery
    Valeur, Eric
    Gueret, Stephanie M.
    Adihou, Helene
    Gopalakrishnan, Ranganath
    Lemurell, Malin
    Waldmann, Herbert
    Grossmann, Tom N.
    Plowright, Alleyn T.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (35) : 10294 - 10323
  • [2] Strategic applications of toxicogenomics in early drug discovery
    Ryan, Timothy P.
    Stevens, James L.
    Thomas, Craig E.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) : 654 - 660
  • [3] Strategic Application of Toxicogenomics in Early Drug Discovery
    Stevens, James
    DRUG METABOLISM REVIEWS, 2010, 42 : 3 - 4
  • [4] Strategic Expansion and Management of Chemical Libraries for Drug Discovery
    Choi, Inhee
    Ko, Yoonae
    Lee, Honggun
    Kim, Kideok
    Radu, Constantin
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2018, 39 (06): : 794 - 800
  • [5] New Modalities and Strategies in Drug Delivery and Discovery Foreword
    Ishida, Tatsuhiro
    Kogure, Kentaro
    Tachikawa, Masanori
    Baba, Kazuhiko
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2022, 70 (05) : 309 - 309
  • [6] Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities
    Han, Bingsong
    Salituro, Francesco G.
    Blanco, Maria-Jesus
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1810 - 1819
  • [7] New therapeutic modalities in drug discovery and development: Insights & opportunities
    Kansy, Manfred
    Caron, Giulia
    ADMET AND DMPK, 2021, 9 (04): : 227 - 230
  • [8] Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development
    Baranczewski, Pawel
    Stanczak, Andrzej
    Kautiainen, Antti
    Sandin, Per
    Edlund, Per-Of
    PHARMACOLOGICAL REPORTS, 2006, 58 (03) : 341 - 352
  • [9] Strategies and Challenges Involved in the Discovery of New Chemical Entities During Early-Stage Tuberculosis Drug Discovery
    Coxon, Geoffrey D.
    Cooper, Christopher B.
    Gillespie, Stephen H.
    McHugh, Timothy D.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 : S258 - S264
  • [10] Drug Hunting at the Nexus of Medicinal Chemistry and Chemical Biology and the Discovery of Novel Therapeutic Modalities
    Palacios, Daniel S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (20) : 13594 - 13613